HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Probi Grows China Reach With Sinopharm deal

Executive Summary

Sinopharm – one of China’s largest pharmaceutical and healthcare companies – will launch in its local market three premium probiotic supplements based upon Probi’s patented strains.

You may also be interested in...

EU Business Round-Up: Probi Signs Oriflame Deal, Holland & Barrett Heads To China, Enzymatica Launches On Amazon

The latest European health & wellness business news: Probi partners with Swedish beauty firm Oriflame for probiotic launch; retailer Holland & Barrett enters the Chinese market with Alibaba's Tmall; and Enzymatica sees ColdZyme growth potential on Amazon.

EU Business Round-Up: Beiersdorf Names New CEO, Probi Posts Q1 Gains, Reig Jofre Heads To Poland

The latest EU business news: Germany's Beiersdorf promotes Vincent Warnery to CEO; Sweden's Probi posts solid gains in Q1; and Spain's Reig Jofre opens subsidiary in Poland.

EU Probiotics News: Strong Year For Probi, BioGaia Struggles, Kerry Targets Biosearch Deal

Latest European Probiotics News: Probi and BioGaia post earnings, with differing results, while Kerry seeks to expand with Spain's Biosearch.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts